Greg Ekchian, KI alum and Stratagen Bio co-founder, talks to Harvard Business School about his device that measures oxygen levels in tumors. The first postdoc to receive a Blavatnik Fellowship, Ekchian combines his passions for science and entrepreneurship as he transforms the sensor that he developed in the Cima Lab into a commercially available tool to improve cancer treatment.